Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients
Alimentary Pharmacology & Therapeutics2019Vol. 50(9), pp. 1009–1018
Citations Over TimeTop 10% of 2019 papers
Christian P. Selinger, Gareth Parkes, A Bassi, Jimmy K. Limdi, Helen Ludlow, Pritash Patel, Melissa Smith, Santosh Saluke, Zandile Ndlovu, Becky George, John Saunders, Mark Adamson, Aileen Fraser, Jenna M. Robinson, Fiona Donovan, Ioanna Parisi, Jude Tidbury, Lynn Gray, Richard Pollok, Glyn Scott, Tim Raine
Abstract
This study validates steroid assessment as a meaningful quality measure and provides a benchmark for this performance indicator in a large cohort. A programme of quality improvement was associated with lower steroid use.
Related Papers
- [Significance and clinical use of non-steroid anti-inflammatory drugs as substitutes for steroids in steroid dependence].(1968)
- [The deleterious effects of steroid and non-steroid anti-inflammatory drugs on diseased joints].(1982)
- → Quality of Care in Inflammatory Bowel Disease: the Role of Steroid Assessment Tool (SAT) - a Review(2020)
- → Vitamin D screening by gastroenterologists is affected by steroid use in Inflammatory Bowel Disease patients(2008)